Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone for treatment of endometrial polyps
IRCT20241203063928N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in endometrial polyp comparing Dydrogesterone with Placebo (2 arms). Primary endpoints: Polyp size and Endometrial thickness. Started Feb 2025; status: completed.
02
Drugs
dydrogesterone
03
Conditions
endometrial polyp
Beyond the preview
Go deeper on IRCT20241203063928N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241203063928N1.